Our professionals’ books, and articles on external publications.
For Publications relating to IP in General, Copyright, Unfair Competition, Plant Variety Protection, etc.,
please select “Intellectual Property.”

「Does a third party infringe a patent right by conducting clinical trials on an original drug?」

Authors YAMAMOTO, Osamu    
Practice Areas Intellectual Property Patents
Date of publication Issue May / June 2021
Publication carrying this article The Patent Lawyer
Publisher CTC Legal Media

PDF Download


Osamu Yamamoto explains the impact of the recent Intellectual Property High Court decision Reiwa 2 (Ne) 10051, as well as the necessity for reforming the patent system relating to drug marketing approval in Japan.

Other works by YAMAMOTO, Osamu

Other works on Intellectual Property、Patents



E-mail for Enquiries

Click Here

Section 206, Shin-Otemachi Bldg.
2-1, Otemachi 2-Chome
Chiyoda-Ku, Tokyo 100-0004, Japan


  • The contents of this site provide readers with general information and are not legal advice.
  • YUASA AND HARA is not responsible to readers who act upon the information contained in this site.

Our privacy policy applies to our online/offline handling of your personal information.